Baxter to Proceed with Recall of Remaining Heparin Sodium Vial Products (Feb. 28)
Baxter International Inc. announced today that the company is proceeding with the voluntary recall of all remaining lots and doses of its heparin sodium injection multi-dose, single-dose vials and HEP-LOCK heparin flush products.
Comments
Readers of this site appreciate your comments
You must be logged in to post a comment.
